Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18642608 | ANTIMICROBIAL ORGANOSILANES | April 2024 | August 2024 | Allow | 4 | 1 | 0 | No | No |
| 18404081 | MONOALKYL TIN COMPOUNDS WITH LOW POLYALKYL CONTAMINATION, THEIR COMPOSITIONS AND METHODS | January 2024 | February 2025 | Allow | 14 | 1 | 0 | No | No |
| 18390624 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | December 2023 | December 2024 | Allow | 12 | 0 | 0 | No | No |
| 18243409 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | September 2023 | October 2024 | Allow | 13 | 0 | 0 | No | No |
| 18333299 | COMPOSITION OF CATALYSTS FOR CONVERSION OF ETHANOL TO N-BUTANOL AND HIGHER ALCOHOLS | June 2023 | June 2025 | Abandon | 24 | 0 | 1 | No | No |
| 18205009 | HIGH PURITY ALKYL TIN COMPOUNDS AND MANUFACTURING METHODS THEREOF | June 2023 | June 2025 | Allow | 25 | 3 | 1 | Yes | No |
| 18201100 | PROCESS FOR PREPARING ORGANOTIN COMPOUNDS | May 2023 | March 2025 | Allow | 22 | 1 | 0 | No | No |
| 18196281 | PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS | May 2023 | March 2025 | Abandon | 22 | 0 | 1 | No | No |
| 18143500 | LOW PRESSURE PROCESS FOR SYNTHESIS OF PT(PF3)4 INVOLVING A SOLUBLE INTERMEDIATE AND STORAGE OF OBTAINED PT(PF3)4 | May 2023 | January 2025 | Allow | 21 | 1 | 0 | No | No |
| 18310214 | COMPOSITION, FILM, DISPLAY DEVICE AND ARTICLE PREPARED THEREFROM, AND METHOD OF PREPARING ARTICLE | May 2023 | April 2025 | Allow | 23 | 1 | 1 | No | No |
| 18192182 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | March 2023 | January 2025 | Allow | 22 | 1 | 0 | No | No |
| 18180056 | SYNTHESIS AND USE OF PRECURSORS FOR ALD OF MOLYBDENUM OR TUNGSTEN CONTAINING THIN FILMS | March 2023 | March 2025 | Allow | 25 | 2 | 1 | Yes | No |
| 18166218 | POLYORGANOSILOXANE, POLYORGANOSILOXANE COMPOSITION, CURED PRODUCT, POLYORGANOSILOXANE-CONTAINING ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR USING SAME | February 2023 | June 2025 | Allow | 28 | 1 | 1 | Yes | No |
| 18165870 | IODINE-CONTAINING METAL COMPOUND AND COMPOSITION FOR DEPOSITING THIN FILM INCLUDING THE SAME | February 2023 | June 2025 | Allow | 28 | 2 | 1 | No | No |
| 18085157 | Synthesis of Spermidine, Spermine, and Free Bases Thereof | December 2022 | December 2024 | Abandon | 23 | 2 | 1 | No | No |
| 18065572 | GOLD NANOPARTICLE SUPERLATTICE EMBEDDED IN POROUS SILICA AND METHOD FOR MANUFACTURING SAME | December 2022 | November 2024 | Allow | 23 | 0 | 1 | No | No |
| 18060291 | PHOTOCHROMIC GERMOLE-FUSED DIARYLETHENES AND PRODUCTION THEREOF | November 2022 | July 2024 | Allow | 20 | 1 | 0 | No | No |
| 17928292 | Complex Containing Betaine, Transition Metal and Sulfate | November 2022 | May 2025 | Allow | 30 | 1 | 0 | No | No |
| 17981433 | ORGANOMETALLIC TIN COMPOUNDS AS EUV PHOTORESIST | November 2022 | November 2024 | Allow | 24 | 1 | 0 | No | No |
| 17901569 | VAPOR DEPOSITION PRECURSOR COMPOUNDS AND PROCESS OF USE | September 2022 | November 2024 | Allow | 26 | 1 | 1 | No | No |
| 17873746 | MULTIMETAL-METAL ORGANIC FRAMEWORK ADSORBENT | July 2022 | April 2025 | Allow | 32 | 1 | 1 | No | No |
| 17849347 | AQUEOUS SOLUTION COMPOSITION CONTAINING ORGANOSILICON COMPOUND | June 2022 | March 2025 | Abandon | 33 | 2 | 0 | No | No |
| 17843021 | PROCESS FOR PREPARING ORGANOTIN COMPOUNDS | June 2022 | December 2024 | Abandon | 30 | 2 | 1 | No | No |
| 17841150 | TWO-DIMENSIONAL COORDINATION POLYMERS | June 2022 | January 2025 | Allow | 31 | 1 | 0 | No | No |
| 17731729 | SUBSTRATE SURFACE MODIFIER FOR ATOMIC LAYER DEPOSITION AND METHOD FOR MODIFYING SURFACE OF SUBSTRATE USING THE SAME | April 2022 | May 2025 | Abandon | 36 | 2 | 1 | No | No |
| 17708673 | P-DIPHENYL COMPOUND DERIVATIVE MIXTURE AND METHOD OF PRODUCING THE SAME | March 2022 | May 2025 | Abandon | 37 | 4 | 1 | Yes | No |
| 17696019 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | March 2022 | September 2024 | Allow | 30 | 4 | 0 | No | No |
| 17692998 | Metal Complexes Containing Cyclopentadienyl Ligands | March 2022 | February 2025 | Allow | 35 | 2 | 0 | Yes | No |
| 17591007 | PROCESS FOR PREPARING ORGANOTIN COMPOUNDS | February 2022 | January 2025 | Allow | 35 | 2 | 0 | No | No |
| 17620900 | METHOD FOR THE PURIFICATION OF ANILINE | December 2021 | May 2025 | Abandon | 41 | 2 | 1 | Yes | No |
| 17644211 | RADIOTHERAPY IMPROVEMENTS | December 2021 | March 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17512722 | GROWTH INHIBITOR FOR FORMING THIN FILM, METHOD FOR FORMING THIN FILM AND SEMICONDUCTOR SUBSTRATE PREPARED THEREFROM | October 2021 | September 2024 | Abandon | 35 | 2 | 1 | No | No |
| 17594282 | LUMINESCENT SILAFLUORENE AND GERMAFLUORENE COMPOUNDS | October 2021 | June 2025 | Allow | 44 | 1 | 1 | No | No |
| 17598762 | METHODS FOR SYNTHESIZING BETA-HOMOAMINO ACIDS | September 2021 | February 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17478283 | HYDROGENATION CATALYST | September 2021 | March 2025 | Abandon | 42 | 2 | 1 | No | No |
| 17464630 | 2D ORGANIC-INORGANIC HYBRID PEROVSKITES AND USES THEREOF | September 2021 | August 2024 | Allow | 36 | 2 | 1 | No | No |
| 17427200 | FLUORESCENT GTP ANALOGUES AND USE | July 2021 | April 2025 | Allow | 45 | 2 | 1 | No | No |
| 17380475 | ORGANOTIN CLUSTERS, SOLUTIONS OF ORGANOTIN CLUSTERS, AND APPLICATION TO HIGH RESOLUTION PATTERNING | July 2021 | June 2024 | Allow | 34 | 3 | 1 | No | No |
| 17365924 | Organic Color Center-Tailored, Semiconducting Carbon Nanotubes and Their Method of Manufacture | July 2021 | February 2025 | Allow | 44 | 4 | 1 | No | No |
| 17351648 | Process For Producing Metal Organic Frameworks | June 2021 | May 2025 | Allow | 47 | 1 | 1 | No | No |
| 17304201 | NOVEL PRODRUG SALTS | June 2021 | September 2024 | Allow | 39 | 1 | 0 | No | No |
| 17342077 | COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | June 2021 | May 2025 | Abandon | 48 | 1 | 1 | No | No |
| 17291873 | CATIONIC LIPIDS CONTAINING SILICON | May 2021 | April 2025 | Allow | 47 | 1 | 1 | No | No |
| 17239991 | CHIRAL N-SUBSTITUTED ALLYLIC AMINE COMPOUNDS | April 2021 | May 2024 | Allow | 36 | 3 | 1 | No | No |
| 17258890 | PROCESS FOR THE PREPARATION OF 2,2',2''-(10-((2R,3S)-1,3,4-TRIHYDROXY BUTAN-2-YL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND ITS COMPLEXES | January 2021 | October 2024 | Allow | 45 | 5 | 1 | No | No |
| 17051970 | PRODUCTION METHOD FOR ORGANIC SILICON COMPOUND HAVING KETIMINE STRUCTURE | October 2020 | November 2024 | Allow | 49 | 2 | 0 | No | No |
| 17051209 | USE OF N-CHELATING RUTHENIUM COMPLEXES IN THE METATHESIS REACTION | October 2020 | December 2024 | Allow | 50 | 2 | 0 | No | No |
| 17049710 | ROTAXANE COMPOUND | October 2020 | January 2025 | Allow | 50 | 2 | 1 | Yes | No |
| 17048372 | ORGANIC SILICON COMPOUND AND PRODUCTION METHOD THEREFOR | October 2020 | October 2024 | Allow | 48 | 1 | 1 | No | No |
| 17027113 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | September 2020 | July 2024 | Allow | 46 | 3 | 1 | No | No |
| 16996543 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | August 2020 | July 2024 | Allow | 47 | 3 | 1 | Yes | No |
| 16933458 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | July 2020 | October 2024 | Allow | 51 | 4 | 0 | Yes | No |
| 16919291 | MATERIAL FOR HOLE-TRANSPORT LAYER, MATERIAL FOR HOLE-INJECTION LAYER, ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | July 2020 | May 2025 | Allow | 58 | 8 | 1 | No | No |
| 16838353 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | April 2020 | February 2025 | Allow | 59 | 6 | 0 | No | No |
| 16651386 | HALOGENATED HETEROALKENYL- AND HETEROALKYL-FUNCTIONALIZED ORGANIC COMPOUNDS AND METHODS FOR PREPARING SUCH COMPOUNDS | March 2020 | March 2025 | Abandon | 59 | 4 | 1 | Yes | No |
| 16734415 | GROWTH INHIBITOR FOR FORMING THIN FILM, METHOD FOR FORMING THIN FILM AND SEMICONDUCTOR SUBSTRATE PREPARED THEREFROM | January 2020 | September 2024 | Abandon | 56 | 7 | 1 | No | No |
| 16665815 | Enhanced Perovskite Materials for Photovoltaic Devices | October 2019 | October 2024 | Allow | 60 | 6 | 1 | No | No |
| 16529213 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | August 2019 | January 2020 | Allow | 6 | 0 | 0 | No | No |
| 16510198 | PYRIMIDINE-THIAZOLIDINONE DERIVATIVES | July 2019 | January 2020 | Allow | 7 | 0 | 0 | Yes | No |
| 16270108 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | February 2019 | March 2025 | Allow | 60 | 8 | 1 | Yes | No |
| 16210492 | HEPATITIS B ANTIVIRAL AGENTS | December 2018 | March 2020 | Allow | 15 | 2 | 0 | No | Yes |
| 16204166 | HEPATITIS B ANTIVIRAL AGENTS | November 2018 | February 2020 | Allow | 15 | 2 | 1 | No | Yes |
| 16151597 | COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | October 2018 | January 2020 | Allow | 16 | 2 | 0 | No | No |
| 15557717 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYCLOPENTYL ACETIC ACID | September 2017 | February 2020 | Allow | 29 | 2 | 1 | No | No |
| 15034797 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAZOPANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | May 2016 | March 2020 | Allow | 47 | 5 | 1 | No | No |
| 14695245 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | April 2015 | November 2015 | Allow | 7 | 0 | 0 | No | No |
| 14573370 | INTERMEDIATES TO PREPARE HERBICIDAL PYRIMIDONE DERIVATIVES | December 2014 | March 2015 | Allow | 3 | 0 | 0 | No | No |
| 14406264 | MULTICOMPONENT CRYSTALS COMPRISING IMATINIB MESILATE AND SELECTED CO-CRYSTAL FORMERS | December 2014 | August 2015 | Allow | 8 | 0 | 0 | No | No |
| 14401941 | TrkA Kinase Inhibitors, Compositions and Methods Thereof | November 2014 | July 2015 | Allow | 8 | 2 | 0 | Yes | No |
| 14495337 | (2-HETEROARYLAMINO) SUCCINIC ACID DERIVATIVES | September 2014 | August 2015 | Allow | 11 | 0 | 1 | No | No |
| 14377951 | AROMATIC RING COMPOUND | August 2014 | July 2015 | Allow | 12 | 0 | 1 | No | No |
| 14375240 | Fungicidal Pyrimidine Compounds | July 2014 | February 2015 | Allow | 7 | 0 | 0 | No | No |
| 14375238 | Fungicidal Pyrimidine Compounds | July 2014 | February 2015 | Allow | 6 | 0 | 0 | No | No |
| 14262915 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | April 2014 | January 2015 | Allow | 8 | 0 | 0 | No | No |
| 14238272 | SUBSTITUTED HETEROCYCLIC AMINE COMPOUNDS AS CHOLESTRYL ESTER-TRANSFER PROTEIN (CETP) INHIBITORS | April 2014 | July 2015 | Allow | 17 | 1 | 1 | No | No |
| 14113214 | FLUOROALKYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF | December 2013 | April 2015 | Allow | 17 | 1 | 1 | No | No |
| 14071953 | CERTAIN PROTEIN KINASE INHIBITORS | November 2013 | July 2015 | Allow | 21 | 2 | 1 | No | No |
| 14051464 | SUBSTITUTED (S)-(2R,3R,5R)-3-HYDROXY-(5-PYRIMIDIN-1-YL)TETRAHYDROFURAN-2-YLMETHYL ARYL PHOSPHORAMIDATE | October 2013 | June 2014 | Allow | 8 | 1 | 0 | No | No |
| 14047815 | NOVEL FLUOROERGOLINE ANALOGS | October 2013 | July 2014 | Allow | 9 | 0 | 0 | No | No |
| 14000261 | GLYCINE TRANSPORTER-INHIBITING SUBSTANCES | August 2013 | April 2014 | Allow | 8 | 1 | 0 | Yes | No |
| 13961218 | 5-CYANO-4- (PYRROLO [2,3B] PYRIDINE-3-YL) -PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS | August 2013 | June 2014 | Allow | 10 | 0 | 0 | Yes | No |
| 13918048 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | June 2013 | February 2014 | Allow | 8 | 0 | 1 | No | No |
| 13991953 | PYRIMIDINONE AND PYRIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP-PLA2 | June 2013 | June 2014 | Allow | 12 | 1 | 1 | No | No |
| 13824552 | NOVEL GPR 119 AGONISTS | June 2013 | April 2014 | Allow | 13 | 1 | 0 | No | No |
| 13905515 | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators | May 2013 | May 2014 | Allow | 12 | 0 | 0 | Yes | No |
| 13702560 | 6-(SULFONYLARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS | May 2013 | May 2014 | Allow | 17 | 0 | 0 | No | No |
| 13989602 | NOVEL POLYMORPH OF NILOTINIB HYDROCHLORIDE | May 2013 | October 2013 | Allow | 5 | 0 | 0 | No | No |
| 13884698 | HETEROCYCLIC COMPOUNDS AND THEIR USES | May 2013 | April 2014 | Allow | 11 | 1 | 1 | Yes | No |
| 13704980 | RING-FUSED 4-AMINOPYRIMIDINES AND USE THEREOF AS STIMULATORS OF SOLUABLE GUANYLATE CYCLASES | February 2013 | November 2013 | Allow | 11 | 0 | 0 | No | No |
| 13773052 | HETEROARYL COMPOUNDS AND THEIR USES | February 2013 | March 2014 | Allow | 12 | 0 | 1 | No | No |
| 13679055 | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators | November 2012 | February 2013 | Allow | 3 | 0 | 0 | Yes | No |
| 13675007 | 1-PYRIDAZINYL-HYDROXYIMINO-3-PHENYL-PROPANES | November 2012 | April 2015 | Allow | 29 | 2 | 1 | No | No |
| 13576296 | INTERMEDIATES FOR THE PREPARATION OF HMG COA REDUCTASE INHIBITORS AND PROCESSES FOR THE PREPARATION THEREOF | October 2012 | March 2014 | Allow | 19 | 0 | 1 | Yes | No |
| 13515782 | PROCESSES FOR THE PREPARATION OF KEY INTERMEDIATE FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | September 2012 | January 2015 | Allow | 31 | 2 | 1 | Yes | No |
| 13593776 | SERINE/THREONINE KINASE INHIBITORS | August 2012 | November 2013 | Allow | 15 | 0 | 1 | No | No |
| 13590955 | CYCLOPROPANE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES | August 2012 | March 2013 | Allow | 7 | 0 | 0 | No | No |
| 13531416 | NOVEL ISO-ERGOLINE DERIVATIVES | June 2012 | September 2013 | Allow | 14 | 0 | 0 | Yes | No |
| 13501418 | INDOLE AND AZAINDOLE MODULATORS OF THE ALPHA 7 NACHR | May 2012 | March 2014 | Allow | 23 | 1 | 1 | No | No |
| 13496799 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | April 2012 | January 2014 | Allow | 22 | 1 | 1 | No | No |
| 13143943 | PROCESS FOR THE PREPARATION OF ROSUVASTATIN SALTS | November 2011 | April 2013 | Allow | 21 | 0 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAGANO, ALEXANDER R.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner PAGANO, ALEXANDER R works in Art Unit 1692 and has examined 140 patent applications in our dataset. With an allowance rate of 88.6%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 29 months.
Examiner PAGANO, ALEXANDER R's allowance rate of 88.6% places them in the 66% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by PAGANO, ALEXANDER R receive 1.59 office actions before reaching final disposition. This places the examiner in the 42% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by PAGANO, ALEXANDER R is 29 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a -0.9% benefit to allowance rate for applications examined by PAGANO, ALEXANDER R. This interview benefit is in the 8% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 23.6% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 54.5% of cases where such amendments are filed. This entry rate is in the 76% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 86% percentile among all examiners. Of these withdrawals, 80.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 59% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 82% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.